PT2977

PT2977 Uses, Dosage, Side Effects, Food Interaction and all others data.

PT2977 is an HIF-2α inhibitor. A kidney cancer treatment, it is the lead candidate drug for Peloton. Peloton was acquired by Merck & Co Inc on May 21, 2019.

Trade Name PT2977
Generic PT2977
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
PT2977
PT2977

Innovators Monograph

You find simplified version here PT2977


*** Taking medicines without doctor's advice can cause long-term problems.
Share